Oryzon Genomics SA (ORY) - Financial and Strategic SWOT Analysis Review

  • ID: 4278901
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Oryzon Genomics SA (Oryzon) is a biopharmaceutical company that offers development of epigenetics-based therapeutics. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup of the genes themselves and provides regulation of gene transcription that has emerged as a key biological determinant of protein production and cellular differentiation. It provides therapeutic programs and collaborative research services. The company serves patients with cancers or neurodegenerative disorders. It offers genomics services to the pharmaceutical industry. Oryzon is headquartered in Barcelona, Spain.

Oryzon Genomics SA Key Recent Developments

Feb 19, 2018: Oryzon revamps its Board with an expert in Biomedicine and Epigenetics in the US industry
Feb 19, 2018: ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2017
Nov 07, 2017: ORYZON Reports Financial Results and Corporate Update for the 3rd Quarter Ended September 30, 2017
Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017
May 16, 2017: Oryzon announces appointment of new Chief Medical Officer and expansion of its Medical Department

This comprehensive SWOT profile of Oryzon Genomics SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oryzon Genomics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Oryzon Genomics SA - Key Information
  • Oryzon Genomics SA - Overview
  • Oryzon Genomics SA - Key Employees
  • Oryzon Genomics SA - Key Employee Biographies
  • Oryzon Genomics SA - Key Operational Heads
  • Oryzon Genomics SA - Major Products and Services
  • Oryzon Genomics SA - History
  • Oryzon Genomics SA - Company Statement
  • Oryzon Genomics SA - Locations And Subsidiaries
  • Oryzon Genomics SA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Oryzon Genomics SA - Business Description
  • Oryzon Genomics SA - Corporate Strategy
  • Oryzon Genomics SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Oryzon Genomics SA - Strengths
  • Oryzon Genomics SA - Weaknesses
  • Oryzon Genomics SA - Opportunities
  • Oryzon Genomics SA - Threats
  • Oryzon Genomics SA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Oryzon Genomics SA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Oryzon Genomics SA, Key Information
  • Oryzon Genomics SA, Key Ratios
  • Oryzon Genomics SA, Share Data
  • Oryzon Genomics SA, Major Products and Services
  • Oryzon Genomics SA, History
  • Oryzon Genomics SA, Key Employees
  • Oryzon Genomics SA, Key Employee Biographies
  • Oryzon Genomics SA, Key Operational Heads
  • Oryzon Genomics SA, Other Locations
  • Oryzon Genomics SA, Subsidiaries
  • Oryzon Genomics SA, Key Manufacturing facilities
  • Oryzon Genomics SA, Key Competitors
  • Oryzon Genomics SA, SWOT Analysis
  • Oryzon Genomics SA, Ratios based on current share price
  • Oryzon Genomics SA, Annual Ratios
  • Oryzon Genomics SA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oryzon Genomics SA, Performance Chart
  • Oryzon Genomics SA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll